Nitrous oxide

Description

Nitrous oxide USP is a gas under pressure, with the chemical name nitrous oxide and a CAS number of 10024-97-2. It is classified under UN1070. The cylinder temperature should not exceed 52 °C (125 °F).

Uses and Indications

This drug is indicated for use in medical settings where Nitrous Oxide is deemed appropriate for analgesia or sedation. Administration of Nitrous Oxide may be hazardous or contraindicated; therefore, it is to be used only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrous Oxide. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of Use: There are no specific teratogenic or nonteratogenic effects associated with this drug mentioned in the available data.

Dosage and Administration

Administration of Nitrous Oxide is intended for respiratory inhalation only. It is crucial that this agent is used exclusively by or under the supervision of a licensed practitioner who possesses experience in its use and administration. The practitioner must be well-versed in the indications, effects, dosages, methods, and frequency and duration of administration.

Due to the potential hazards and contraindications associated with Nitrous Oxide, careful consideration must be given to the patient's condition and the specific clinical context prior to administration. Practitioners should ensure that they are familiar with the appropriate dosing ranges and intervals, as well as any necessary preparation techniques to ensure safe and effective use.

Contraindications

Use of this product is contraindicated in the following situations:

Handling of the product should not occur until all safety precautions have been thoroughly read and understood. Direct contact with eyes, skin, or clothing must be avoided to prevent potential irritation or harm. Inhalation of gas is contraindicated; therefore, it is essential to avoid breathing in any vapors. Additionally, the product should only be used and stored outdoors or in a well-ventilated area to minimize exposure risks.

Warnings and Precautions

Administration of Nitrous Oxide is associated with significant risks and should only be performed by or under the supervision of a licensed practitioner who possesses expertise in its use. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Fire and Explosion Hazards Nitrous Oxide is an oxidizer and may cause or intensify fire. It is crucial to handle this gas with caution, as it is stored under pressure and may explode if subjected to heat. Therefore, it is imperative to keep and store Nitrous Oxide away from combustible materials and clothing. Valves and fittings must be kept free from oil and grease to minimize the risk of ignition.

Health Risks The use of Nitrous Oxide may lead to drowsiness or dizziness. Additionally, it can displace oxygen in the environment, posing a risk of rapid suffocation. Users should avoid inhaling the gas and ensure that it does not come into contact with the eyes, skin, or clothing. Frostbite is another potential risk associated with exposure; immediate medical attention should be sought in such cases.

Safety Precautions Prior to handling Nitrous Oxide, all safety precautions must be thoroughly read and understood. It is recommended to use and store the gas only outdoors or in well-ventilated areas. In the event of a fire, efforts should be made to stop the leak if it is safe to do so. Equipment used with Nitrous Oxide must be rated for cylinder pressure, and a backflow prevention device should be employed in the piping. Only equipment that has been cleaned for oxygen service should be utilized.

Operational Guidelines When opening the valve, it should be done slowly, and the valve must be closed after each use and when the cylinder is empty. The temperature of the cylinder should not exceed 52°C (125°F). It is essential to follow the guidelines outlined in the Safety Data Sheet for this product.

First Aid Measures In the event of inhalation, the individual should be removed to fresh air. If the person is not breathing, artificial respiration should be administered. If breathing difficulties arise, oxygen should be provided, and a physician should be contacted immediately. In cases of frostbite, prompt medical attention is necessary.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this product. Serious warnings include the potential to cause or intensify fire, as it is classified as an oxidizer. Additionally, it may cause drowsiness or dizziness, which could impact the ability to perform tasks requiring alertness. There is also a risk of oxygen displacement, which can lead to rapid suffocation, and exposure may result in frostbite.

In the event of inhalation, it is critical to remove the patient to fresh air immediately. If the patient is not breathing, artificial respiration should be administered, and if breathing difficulties arise, supplemental oxygen should be provided. It is essential to contact a physician for further evaluation and management. In cases of frostbite, obtaining immediate medical attention is necessary to mitigate potential complications.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

The administration of Nitrous Oxide in pediatric patients may pose hazards or be contraindicated. It is essential that Nitrous Oxide is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The administration of Nitrous Oxide during pregnancy may pose potential risks and is considered hazardous or contraindicated. Pregnant patients should be closely monitored, and the use of Nitrous Oxide should only occur under the supervision of a licensed practitioner experienced in its administration.

Healthcare professionals are advised to ensure that all safety precautions are thoroughly read and understood before handling Nitrous Oxide. Given the potential implications for fetal outcomes, caution is warranted when considering the use of this agent in women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of Nitrous Oxide in lactating mothers. Additionally, there are no specific considerations or precautions related to lactation mentioned in the provided text. Therefore, healthcare professionals may consider the use of Nitrous Oxide in nursing mothers without specific concerns related to breastfeeding.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the insert for Nitrous Oxide. Therefore, healthcare professionals should exercise caution when administering this agent to patients with reduced kidney function, as the absence of data limits the ability to make informed decisions regarding its use in this population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrous Oxide. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this patient population. It is recommended that healthcare providers exercise caution and consider the overall clinical context when administering Nitrous Oxide to patients with compromised liver function.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential risks associated with excessive dosing of the medication.

Healthcare providers should be aware that symptoms of overdosage may vary depending on the pharmacological properties of the drug in question. In cases where overdosage is suspected, it is recommended to monitor the patient closely for any adverse effects or unusual clinical signs.

Management of overdosage should be guided by the severity of symptoms and may include supportive care, symptomatic treatment, and, if applicable, the use of specific antidotes. It is advisable to consult local poison control centers or relevant clinical guidelines for further assistance in managing suspected overdosage cases.

In summary, while no specific overdosage information is provided, healthcare professionals should exercise caution and implement appropriate monitoring and management strategies in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Postmarketing experience has revealed the following adverse reactions reported voluntarily or through surveillance programs: drowsiness, dizziness, and frostbite.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide may pose hazards and is contraindicated in certain situations. It is essential that this substance is used only by or under the supervision of a licensed practitioner who is experienced in its use and familiar with its indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be informed that Nitrous Oxide is an oxidizer and may cause or intensify fire. They should be made aware that the gas is stored under pressure and may explode if heated. Additionally, patients should be cautioned that the use of Nitrous Oxide may lead to drowsiness or dizziness, and it can displace oxygen, potentially causing rapid suffocation. Frostbite is another risk associated with this gas.

Healthcare providers should emphasize the importance of understanding all safety precautions before handling Nitrous Oxide. Patients should be instructed to keep the gas away from combustible materials and clothing, and to ensure that valves and fittings are free from oil and grease. They should avoid breathing the gas and prevent contact with eyes, skin, or clothing. It is crucial to use and store Nitrous Oxide only outdoors or in a well-ventilated area.

In the event of a fire, patients should be advised to stop the leak if it is safe to do so. They should only use equipment that is rated for cylinder pressure and utilize a backflow prevention device in the piping. Equipment must be cleaned for oxygen service, and the valve should be opened slowly. Patients should close the valve after each use and when the cylinder is empty, and they should be aware that the cylinder temperature should not exceed 52°C (125°F).

Healthcare providers should recommend that patients refer to the Safety Data Sheet for this product for detailed information. In case of inhalation, patients should be instructed to move to fresh air immediately. If not breathing, they should receive artificial respiration, and if breathing is difficult, they should be given oxygen. It is important to call a physician in such cases. In the event of frostbite, patients should seek immediate medical attention.

Storage and Handling

The product is supplied in cylinders that must be stored away from combustible materials and clothing. It is essential to keep valves and fittings free from oil and grease to ensure safe handling. Users should avoid breathing the gas and prevent contact with eyes, skin, or clothing.

For optimal safety, the product should only be used and stored outdoors or in a well-ventilated area. The temperature of the cylinder must not exceed 52°C (125°F). When using the product, the valve should be opened slowly, and it is crucial to close the valve after each use and when the cylinder is empty.

Users are advised to follow the guidelines outlined in the Safety Data Sheet for this product to ensure proper handling and storage.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by Helget Gas Products. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)